Abstract
In order to study the in vivo performance and in vitro cytotoxicity of 10-hydroxycamptothecin (10-HCPT) nanosuspension developed in our previous work. For investigating the pharmacokinetics in rats and the tissue distribution in mice with10-HCPT nanosuspension and the 10-HCPT solution, 10-HCPT nanosuspension and 10-HCPT solution were intravenously administered to rats via caudal vein, respectively. And 10-HCPT nanosuspension was intravenously injected to mice to study tissue distribution as compared to 10- HCPT solution. Serum samples and tissue homogenates were analyzed by HPLC-FD, then pharmaceutics parameters were calculation. In vitro cytotoxicity was also carried out with MCF-7/Ard and PC-3 as cell models. The results showed 10-HCPT nanosuspension could decrease plasma peak concentration and extend plasma circulating time compared to 10-HCPT solution. And the biodistribution test indicated that 10-HCPT nanosuspension can markedly change in vivo distribution pattern in comparison to 10-HCPT solution, and had considerable passive targeting capability to the mononuclear phagocyte systems. The in vitro cytotoxicity test demonstrated 10-HCPT nanosuspension had greater cytotoxicity to cancer cells than the solution, especially for adriamycin-sensitive cells. So the nanosuspensions will be a promising formulation strategy to resolve questions on solubility and increase anti-tumor activity of the poorly soluble anticancer compounds.
Keywords: 10-Hydroxycamptothecin, nanosuspensions, pharmacokinetics, tissue distribution, cytotoxicity.
Current Nanoscience
Title:The Passive Targeting and the Cytotoxicity of Intravenous 10-HCPT Nanosuspension
Volume: 8 Issue: 5
Author(s): Xiaohui Pu, Jin Sun, Yimeng Qin, Xiao Zhang, Peng Zhang, Zhongtian Yan and Zhonggui He
Affiliation:
Keywords: 10-Hydroxycamptothecin, nanosuspensions, pharmacokinetics, tissue distribution, cytotoxicity.
Abstract: In order to study the in vivo performance and in vitro cytotoxicity of 10-hydroxycamptothecin (10-HCPT) nanosuspension developed in our previous work. For investigating the pharmacokinetics in rats and the tissue distribution in mice with10-HCPT nanosuspension and the 10-HCPT solution, 10-HCPT nanosuspension and 10-HCPT solution were intravenously administered to rats via caudal vein, respectively. And 10-HCPT nanosuspension was intravenously injected to mice to study tissue distribution as compared to 10- HCPT solution. Serum samples and tissue homogenates were analyzed by HPLC-FD, then pharmaceutics parameters were calculation. In vitro cytotoxicity was also carried out with MCF-7/Ard and PC-3 as cell models. The results showed 10-HCPT nanosuspension could decrease plasma peak concentration and extend plasma circulating time compared to 10-HCPT solution. And the biodistribution test indicated that 10-HCPT nanosuspension can markedly change in vivo distribution pattern in comparison to 10-HCPT solution, and had considerable passive targeting capability to the mononuclear phagocyte systems. The in vitro cytotoxicity test demonstrated 10-HCPT nanosuspension had greater cytotoxicity to cancer cells than the solution, especially for adriamycin-sensitive cells. So the nanosuspensions will be a promising formulation strategy to resolve questions on solubility and increase anti-tumor activity of the poorly soluble anticancer compounds.
Export Options
About this article
Cite this article as:
Pu Xiaohui, Sun Jin, Qin Yimeng, Zhang Xiao, Zhang Peng, Yan Zhongtian and He Zhonggui, The Passive Targeting and the Cytotoxicity of Intravenous 10-HCPT Nanosuspension, Current Nanoscience 2012; 8 (5) . https://dx.doi.org/10.2174/157341312802884553
DOI https://dx.doi.org/10.2174/157341312802884553 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Design and Synthesis of Some Newer Pyrimidine Hydroxamates as Histone Deacetylase Inhibitors
Current Enzyme Inhibition Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
Current Cancer Drug Targets A Progressive Review of V600E-B-RAF-Dependent Melanoma and Drugs Inhibiting It
Mini-Reviews in Medicinal Chemistry Future Prospects for Old Chemotherapeutic Drugs in the Target-Specific Era; Pharmaceutics, Combinations, Co-Drugs and Prodrugs with Melphalan as an Example
Letters in Drug Design & Discovery Gut Epithelial Lining Makes the First Move
Current Immunology Reviews (Discontinued) Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT
Current Cancer Drug Targets Recent Studies on Inhibition of Enzymes Leading to Prostate and Breast Cancers
Current Enzyme Inhibition Apoptosis Signaling Pathways in Anticancer Therapy
Current Cancer Therapy Reviews Pleiotropic Role of HSF1 in Neoplastic Transformation
Current Cancer Drug Targets Anticancer Potential of Pulicaria crispa Extract on Human Breast Cancer MDA-MB-231 Cells
Letters in Drug Design & Discovery The Use of Microarrays to Study Childhood Developmental Brain Disorders
Current Genomics Targeting Vesicle Trafficking: An Important Approach to Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Imaging Strategies for Rectal Cancer Initial Staging: Does Pelvic Computed Tomography Provide Significantly Additional Findings when High-resolution Magnetic Resonance Imaging has Been Performed?
Current Medical Imaging Targeted Therapies in Bone Sarcomas
Current Cancer Drug Targets Ribonucleotide Reductase: A Critical Enzyme for Cancer Chemotherapy and Antiviral Agents
Recent Patents on Anti-Cancer Drug Discovery Highlights in Peptide Nanoparticle Carriers Intended to Oral Diseases
Current Topics in Medicinal Chemistry Application of 3-methylene- and 3-(monosubstituted)alkylideneoxindoles in the Synthesis of Heterocyclic Compounds
Current Organic Chemistry A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts
Anti-Cancer Agents in Medicinal Chemistry Molecular Classification and Drug Response Prediction in Cancer
Current Drug Targets Plumbagin Inhibits Breast Tumor Bone Metastasis and Osteolysis by Modulating the Tumor-Bone Microenvironment
Current Molecular Medicine